Is TRIRF or MRK a better dividend investment in 2026?

TRIRF currently yields 2857.14% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: TRIRF offers higher current income.

What is the dividend yield difference between TRIRF and MRK?

TRIRF has a forward dividend yield of 2857.14% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 2854.38 percentage points.

Home › Compare › TRIRF vs MRK

TRIRF vs MRK: Dividend Comparison 2026

TRIRF yields 2857.14% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TRIRF wins by $285724556560.03M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TRIRF

● Live price

2857.14%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$285724556560.08M

Annual income

$267,319,527,558,731,650.00

Full TRIRF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — TRIRF vs MRK

📍 TRIRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TRIRF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TRIRF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TRIRF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRIRF

Annual income on $10K today (after 15% tax)

$242,857.14/yr

After 10yr DRIP, annual income (after tax)

$227,221,598,424,921,900.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, TRIRF beats the other by $227,221,598,424,913,570.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRIRF + MRK for your $10,000?

TRIRF: 50%MRK: 50%

100% MRK50/50100% TRIRF

Portfolio after 10yr

$142862278280.07M

Annual income

$133,659,763,779,370,720.00/yr

Blended yield

93.56%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TRIRF

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

1.1

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRIRF buys

MRK buys

No recent congressional trades found for TRIRF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTRIRFMRK

Forward yield	2857.14% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$285724556560.08M ✓	$56.8K
Annual income after 10y	$267,319,527,558,731,650.00 ✓	$9,798.13
Total dividends collected	$284448663636.43M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: TRIRF vs MRK ($10,000, DRIP)

Year	TRIRF Portfolio	TRIRF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$296,414	$285,714.29	$11,206	$366.19	+$285.2K → TRIRF
2	$8,232,097	$7,914,934.20	$12,650	$502.35	+$8.22M → TRIRF
3	$214,243,566	$205,435,221.63	$14,407	$694.19	+$214.23M → TRIRF
4	$5,225,999,702	$4,996,759,086.15	$16,585	$967.82	+$5225.98M → TRIRF
5	$119,502,966,841	$113,911,147,159.88	$19,342	$1,363.89	+$119502.95M → TRIRF
6	$2,562,267,139,226	$2,434,398,964,706.24	$22,913	$1,947.19	+$2562267.12M → TRIRF
7	$51,522,962,512,220	$48,781,336,673,248.19	$27,662	$2,823.89	+$51522962.48M → TRIRF
8	$971,869,901,477,056	$916,740,331,588,980.50	$34,159	$4,173.35	+$971869901.44M → TRIRF
9	$17,200,961,683,505,388	$16,161,060,888,924,940.00	$43,337	$6,308.80	+$17200961683.46M → TRIRF
10	$285,724,556,560,082,430	$267,319,527,558,731,650.00	$56,776	$9,798.13	+$285724556560.03M → TRIRF

TRIRF vs MRK: Complete Analysis 2026

TRIRF — Stock

Triterras, Inc. operates as a fintech company in the United Arab Emirates, Singapore, Hong Kong, Malaysia, and internationally. It operates Kratos, a digital platform for trade finance and physical trading that connects and enables commodity traders and lenders to transact online. The company serves small and medium sized enterprises. Triterras, Inc. was incorporated in 2018 and is headquartered in Singapore.

Full TRIRF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this TRIRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRIRF vs SCHD TRIRF vs JEPI TRIRF vs O TRIRF vs KO TRIRF vs MAIN TRIRF vs JNJ TRIRF vs ABBV TRIRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.